Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage

References

• Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an interna-tional collaboration. International Stroke Incidence Collabora-tion. Stroke 1997; 28: 491–9.
   PubMed Web of Science ®Google Scholar
• Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007; 6: 456–64.
   PubMed Web of Science ®Google Scholar
• Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Katafuchi R, Hirakata H, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese commu-nity: the Hisayama study. Stroke 2003; 34: 2349–54.
   PubMed Web of Science ®Google Scholar
• Jia Q, Liu LP, Wang YJ. Stroke in China. Clin Exp Pharmacol Physiol 2010; 37: 259–64.
   PubMed Web of Science ®Google Scholar
• Qureshi Al, Mendelow AD, Hanley DF. Intracerebral hae-morrhage. Lancet 2009; 373: 1632–44.
   PubMed Web of Science ®Google Scholar
• van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9: 167–76.
   PubMed Web of Science ®Google Scholar
• Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66: 1175–81.
   PubMed Web of Science ®Google Scholar
• Gebel JM, Jr, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2636–41.
   PubMed Web of Science ®Google Scholar
• Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593–615.
   PubMed Web of Science ®Google Scholar
• Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265–9.
   PubMed Web of Science ®Google Scholar
• Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B, et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 1997; 29: 479–85.
   PubMed Web of Science ®Google Scholar
• Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651–5.
   PubMed Web of Science ®Google Scholar
• Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774–7.
   PubMed Web of Science ®Google Scholar
• Boger RH, Bode-Boger SM, Kienke S, Nafe R, Stan AC, Frolich JC. Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in choles-terol-fed rabbits. Atherosclerosis 1998; 136: 67–77.
   PubMed Web of Science ®Google Scholar
• Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, et al. Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler Thromb Vasc Biol 2001; 21: 201–7.
   PubMed Web of Science ®Google Scholar
• Gao Y. The multiple actions of NO. Pflogers Archiv Eur J Physiol 2010; 459: 829–39.
   Web of Science ®Google Scholar
• Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008; 27: 2783–02.
   PubMed Web of Science ®Google Scholar
• Contestabile A. Role of nitric oxide in cerebellar development and function: focus on granule neurons. Cerebellum 2010; 16: 435–52.
   Google Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424–37.
   PubMed Web of Science ®Google Scholar
• Wink DA, Osawa Y, Darbyshire JF, Jones CR, Eshenaur SC, Nims RW. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys 1993; 300: 115–23.
   PubMed Web of Science ®Google Scholar
• Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991; 174: 761–7.
   PubMed Web of Science ®Google Scholar
• Zhang J, Dawson VU, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994; 263: 687–9.
   PubMed Web of Science ®Google Scholar
• Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345: 50–4.
   Google Scholar
• Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995; 1271: 67–4.
   PubMed Web of Science ®Google Scholar
• Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328: 309–16.
   PubMed Web of Science ®Google Scholar
• Mayhan WG. Nitric oxide donor-induced increase in perme-ability of the blood-brain barrier. Brain Res 2000; 866: 101–8.
   PubMed Web of Science ®Google Scholar
• Mayhan WG, Didion SP. Glutamate-induced disruption of the blood-brain barrier in rats. Role of nitric oxide. Stroke 1996; 27: 965–9.
   Google Scholar
• Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994; 263: 973–77.
   PubMed Web of Science ®Google Scholar
• Kuhlmann CR, Gerigk M, Bender B, Closhen D, Lessmann V, Luhmann HJ. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro. Life Sci 2008; 82: 1281–7.
   PubMed Web of Science ®Google Scholar
• Manabe S, Gu Z, Lipton SA. Activation of matrix metallo-proteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 2005; 46: 4747-53.
   Google Scholar
• Lee CZ, Xue Z, Hao Q, Yang GY, Young WL. Nitric oxide in vascular endothelial growth factor-induced focal angiogenesis and matrix metalloproteinase-9 activity in the mouse brain. Stroke 2009; 40: 2879-81.
   Google Scholar
• McDermott JR. Studies on the catabolism of Ng-methylargi-nine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J 1976; 154: 179–84.
   PubMed Web of Science ®Google Scholar
• Blackwell S. The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine. Ann Clin Biochem 2010;47(Pt 1):17–28.
   PubMed Web of Science ®Google Scholar
• Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: 11127–32.
   Web of Science ®Google Scholar
• Cardounel AJ, Zweier JL. Endogenous methylarginines reg-ulate neuronal nitric-oxide synthase and prevent excitotoxic injury. J Biol Chem 2002; 277: 33995–4002.
   PubMed Web of Science ®Google Scholar
• Fickling SA, Holden DP, Cartwright JE, Nussey SS, Vallance P, Whitley GS. Regulation of macrophage nitric oxide synthesis by endothelial cells: a role for NG,NG-dimethylarginine. Acta Physiol Scand 1999; 167: 145–50.
   PubMedGoogle Scholar
• Anthony S, Leiper J, Vallance P. Endogenous production of nitric oxide synthase inhibitors. Vasc Med 2005;10(Suppl. 1): S3-9.
   Google Scholar
• Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 2004; 24: 1023–30.
   PubMed Web of Science ®Google Scholar
• Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, et al. Identification of two human dimethy-larginine dimethylaminohydrolases with distinct tissue distribu-tions and homology with microbial arginine deiminases. Biochem J 1999;343(Pt 1):209–14.
   PubMed Web of Science ®Google Scholar
• Sydow K, Munzel T. ADMA and oxidative stress. Atheroscler Suppl 2003; 4: 41–51.
   PubMed Web of Science ®Google Scholar
• Wells SM, Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol 2007; 36: 520–8.
   PubMed Web of Science ®Google Scholar
• Sharma S, Smith A, Kumar S, Aggarwal S, Rehmani I, Snead C, et al. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine. Vascul Pharmacol 2010; 52: 182–90.
   PubMed Web of Science ®Google Scholar
• Sud N, Wells SM, Sharma S, Wiseman DA, Wilham J, Black SM. Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am J Physiol Cell Physiol 2008; 294: C1407-18.
   Google Scholar
• Chen MF, Xie XM, Yang TL, Wang YJ, Zhang XH, Luo BL, et al. Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. J Vasc Res 2007; 44: 391–402.
   PubMed Web of Science ®Google Scholar
• Jiang JL, Wang S, Li NS, Zhang XH, Deng HW, Li YJ. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells. Biochem Cell Biol 2007; 85: 66–77.
   PubMed Web of Science ®Google Scholar
• Zhang GG, Bai YP, Chen MF, Shi RZ, Jiang DJ, Fu QM. Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. Vascul Pharmacol 2008; 48: 115–21.
   PubMed Web of Science ®Google Scholar
• Wojciak-Stothard B, Torondel B, Tsang LY, Fleming I, Fisslthaler B. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility. J Cell Sci 2007; 120: 929–42.
   PubMed Web of Science ®Google Scholar
• Scalera F, Borlak J, Beckmann B, Martens-Lobenhoffer J, Thum T, Tager M, et al. Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothe-lial cell senescence. Arterioscler Thromb Vasc Biol 2004; 24: 1816–22.
   PubMed Web of Science ®Google Scholar
• Augustyniak RA, Victor RG, Morgan DA, Zhang W. L-NAME- and ADMA-induced sympathetic neural activation in conscious rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R726–32.
   PubMed Web of Science ®Google Scholar
• Toth J, Racz A, Kaminski PM, Wolin MS, Bagi Z, Koller A. Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. Hypertension 2007; 49: 563–8.
   PubMed Web of Science ®Google Scholar
• Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, et al. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation. Stroke 2008; 39: 180–4.
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Donnerstag F, Gasper S, Menne. J, Kielstein A, Martens-Lobenhoffer J, et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 2006; 37: 2024–9.
   PubMed Web of Science ®Google Scholar
• McBride AE, Silver P. State of the Arg: protein methylation at arginine comes of age. Cell 2001; 106: 5–8.
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 2005; 46: 186–202.
   PubMed Web of Science ®Google Scholar
• Maas R, Erdmann J, Luneburg N, Stritzke J, Schwedhelm E, Meisinger C, et al. Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension. Pharmacol Res 2009; 60: 488–93.
   PubMed Web of Science ®Google Scholar
• Vladimirova-Kitova L, Terzieva D, Marinov B. Intima-media thickness and flow-mediated vasodilation in asymptomatic subjects with newly detected severe hypercholesterolemia. Echocardiography 2009; 26: 1060–8.
   PubMed Web of Science ®Google Scholar
• Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, et al. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Atherosclerosis 2006; 189: 236–40.
   PubMed Web of Science ®Google Scholar
• Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, et al. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes. PLoS One 2010; 5: e9462.
   PubMed Web of Science ®Google Scholar
• Saitoh M, Osanai T, Kamada T, Matsunaga T, Ishizaka H, Hanada H, et al. High plasma level of asymmetric dimethy-larginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level. Heart Vessels 2003; 18: 177–82.
   PubMed Web of Science ®Google Scholar
• Gorenflo M, Zheng C, Werle E, Fiehn W, Ulmer HE. Plasma levels of asymmetrical dimethyl-L-arginine in patients with con-genital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol 2001; 37: 489–92.
   PubMed Web of Science ®Google Scholar
• Wilson AM, Shin DS, Weatherby C, Harada RK, Ng MK, Nair N, et al. Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. Vasc Med 2010; 15: 267–74.
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Zoccali C. Clinical implications of elevated asymmetric dimethylarginine in chronic kidney disease and end-stage renal disease. J Ren Nutr 2009; 19: 25–28.
   PubMed Web of Science ®Google Scholar
• Nanayakkara PW, Teerlink T, Stehouwer CD, Allajar D, Spijkerman A, Schalkwijk C, et al. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concen-tration in patients with mild-to-moderate renal failure. Kidney Int 2005; 68: 2230-36.
   Google Scholar
• Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001; 358: 2127–8.
   PubMed Web of Science ®Google Scholar
• Mittermayer F, Krzyzanowska K, Exner M, Mlekusch W, Amighi J, Sabeti S, et al. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 2536–40.
   PubMed Web of Science ®Google Scholar
• Pikula A, Boger RH, Beiser AS, Maas R, Decarli C, Schwedhelm E, et al. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study. Stroke 2009; 40: 2959–64.
   PubMed Web of Science ®Google Scholar
• Tsuda K. Asymmetric dimethylarginine and hypertension in cerebral small vessel disease. Stroke 2007; 38: e48.
   PubMed Web of Science ®Google Scholar
• Nishiyamaa Y, Ueda M, Katsura K, Otsuka T, Abe A, Nagayama H, et al. Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke. J Neurol Sci 2010; 290: 12–5.
   PubMed Web of Science ®Google Scholar
• Brouns R, Marescau B, Possemiers I, Sheorajpanday R, de Deyn PP. Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochem Res 2009; 34: 1642–9.
   PubMed Web of Science ®Google Scholar
• Worthmann H, Chen SF, Jens Martens-Lobenhoffer J, Li N, Deb M, Tryc AB, etal. High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke. 2010.
   Google Scholar
• Ryu J, Pyo H, Jou I, Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J Biol Chem 2000; 275: 29955–9.
   PubMed Web of Science ®Google Scholar
• Wu J, Yang S, Xi G, Song S, Fu G, Keep RF, etal. Microglial activation and brain injury after intracerebral hemorrhage. Acta Neurochir Suppl 2008; 105: 59–65.
   PubMedGoogle Scholar
• Davis RL, Buck DJ, Saffarian N, Mohan S, DeSilva U, Fernando SC, et al. Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells. J Neuroimmune Pharmacol 2008; 3: 150–3.
   PubMed Web of Science ®Google Scholar
• Mitrovic B, St Pierre BA, Mackenzie-Graham AJ, Merrill JE. The role of nitric oxide in glial pathology. Ann NY Acad Sci 1994; 738: 436–46.
   PubMed Web of Science ®Google Scholar
• Laird MD, Wakade C, Alleyne CH, Jr, Dhandapani KM. Hemin-induced necroptosis involves glutathione depletion in mouse astrocytes. Free Radic Biol Med 2008; 45: 1103–14.
   PubMed Web of Science ®Google Scholar
• Klatt P, Schmidt K, Uray G, Mayer B. Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate. J Biol Chem 1993; 268: 14781–7.
   Google Scholar
• Wanby P, Teerlink T, Brudin L, Brattstrom L, Nilsson I, Palmqvist P, et al. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis 2006; 185: 271–7.
   PubMed Web of Science ®Google Scholar
• Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001; 21: 804–10.
   PubMed Web of Science ®Google Scholar
• Carhuapoma JR, Wang PY, Beauchamp NJ, Keyl PM, Hanley DF, Barker PB. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke 2000; 31: 726–32.
   PubMed Web of Science ®Google Scholar
• Bauser-Heaton HD, Bohlen HG. Cerebral microvascular dilation during hypotension and decreased oxygen tension: a role for nNOS. Am J Physiol Heart Circ Physiol 2007; 293: H2193–201.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang Y, Strong R, Grotta JC, Aronowski J. Distinct patterns of intracerebral hemorrhage-induced alterations in NF-kappa B subunit, iNOS, and COX-2 expression. J Neuro-chem 2007; 101: 652–63.
   PubMed Web of Science ®Google Scholar
• Kim DW, Im SH, Kim JY, Oh GT, Jeong SW. Decreased brain edema after collagenase-induced intracerebral hemorrhage in mice lacking the inducible nitric oxide synthase gene. Laboratory investigation. J Neurosurg 2009; 111: 995–1000.
   PubMed Web of Science ®Google Scholar
• Chiang MF, Chiu WT, Lin FJ, Thajeb P, Huang CJ, Tsai SH. Multiparametric analysis of cerebral substrates and nitric oxide delivery in cerebrospinal fluid in patients with intracerebral haemorrhage: correlation with hemodynamics and outcome. Acta Neurochir (Wien) 2006; 148: 615–21.
   PubMed Web of Science ®Google Scholar
• Rashid PA, Whitehurst A, Lawson N, Bath PM. Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relation-ship with severity and outcome. J Stroke Cerebrovasc Dis 2003; 12: 82–7.
   PubMedGoogle Scholar
• Bai Y, Chen J, Sun K, Xin Y, Liu J, Hui R. Common genetic variation in DDAH2 is associated with intracerebral haemor-rhage in a Chinese population: a multi-centre case-control study in China. Clin Sci (Lond) 2009; 117: 273–9.
   PubMed Web of Science ®Google Scholar
• Pluta RM, Jung CS, Harvey-White J, Whitehead A, Shilad S, Espey MG, et al. In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospasm in primates.J Neurosurg 2005; 103: 731-8.
   Google Scholar
• Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurol Res 2006; 28: 730–7.
   PubMed Web of Science ®Google Scholar
• Jung CS, Iuliano BA, Harvey-White J, Espey M, Oldfield EH, Pluta PM. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 2004; 101: 836–42.
   PubMed Web of Science ®Google Scholar
• Jung CS, Oldfield EH, Harvey-White J, Espey MG, Zimmermann M, Seifert V, et al. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2007; 107: 945–50.
   PubMed Web of Science ®Google Scholar